• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PXL161407
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 03/14/2022
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2011 the patient underwent evar for an abdominal aortic aneurysm and was implanted with gore® excluder® aaa endoprostheses.As reported the disease continued to progress and as it progressed the distal seal was lost.As reported the distal endoleak was off of the ipsilateral side (on the patient¿s left) where the gore® excluder® aaa iliac extender endoprosthesis was initially implanted.On (b)(6) 2022 the patient underwent reintervention in which the physician put an amplatzer plug into the left hypogastric artery and extended into the external iliac artery with a plc121400 (sn: (b)(4)).The patient tolerated the procedure and it was confirmed that there were no endoleaks at the conclusion of the procedure.As reported there were no issues with the implanted endoprostheses and the event was purely related to ongoing disease progression.
 
Additional Manufacturer Narrative
According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require additional intraoperative procedure time or intervention include, but are not limited to endoleak and aneurysm enlargement.
 
Additional Manufacturer Narrative
H6: added component code 515, stent.
 
Additional Manufacturer Narrative
H6: updated investigation conclusion codes to include only code 50.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
breanna cox
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key13802927
Report Number2953161-2022-01128
Device Sequence Number5032929
Product Code MIH
UDI-Device Identifier00733132610082
UDI-Public00733132610082
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 07/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/31/2014
Device Model NumberPXL161407
Device Catalogue NumberPXL161407
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 03/15/2022
Supplement Date Received by Manufacturer03/15/2022
07/20/2022
Initial Report FDA Received Date03/17/2022
Supplement Report FDA Received Date03/23/2022
07/20/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/10/2011
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Other; Required Intervention;
Patient Age82 YR
Patient SexMale
Patient Weight99 KG
-
-